Weifeng Xu

6PUBLICATIONS
16CO-AUTHORS
Characterisation of biological macromoleculesNanotoxicology, health and safetyInfectious agentsGlycoconjugatesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2026
Strategy for streamlining antibody-drug conjugate pharmacokinetic assays.

Weifeng Xu, Linlin Luo, Murali Matta

|Aug 13, 2025
Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays.

Michael A Partridge, Lynn Kamen, Bonnie Wu

|Aug 12, 2025
Low Intrinsic Killing Activity and no Impact of Its Positivity on Phase 3 Pneumococcal Vaccine Adult Studies.

Weifeng Xu, Joseph Antonello, Jennifer Nguyen

|Mar 29, 2024
Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody-Drug Conjugate.

Weifeng Xu, Nazneen Bano, Olguitza Guzman-Valdes

|Jan 25, 2023
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies.

Dilki Wickramarachchi, Julianne Wagner, Thomas Woo

|Sep 27, 2022
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis.

Weifeng Xu, Brian Maas, Brad Roadcap

Pageof 1

Frequent Collaborators

1 joint publications

Heather L Platt

1 joint publications

Marie Bonhomme

1 joint publications

Michael A Partridge

1 joint publications

Lynn Kamen